NSC-357704

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNSC-357704
Drug Alias NameNSC-357704
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn Ab
Active IndicationsN/A
Inactive IndicationsLeukemiaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A